Related Experiment Video
Updated: Feb 5, 2026

Fertility Preservation in Patients with Severe Ovarian Dysfunction
Published on: March 25, 2021
Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction
Divyanshu Dubey1, Naga Kothapalli2, Andrew McKeon3
1Department of Neurology, Mayo Clinic, Rochester, United States; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States; Department of Neurology, Massachusetts's General Hospital, Boston, United States.
Abstract:
Recognition of autoimmunity as a cause of encephalopathy has increased. Recent studies have validated the use of Antibody-Prevalence-in-Epilepsy (APE) and Responsive-to-immunotherapy-in-Epilepsy (RITE) scores in the evaluation and management of autoimmune-epilepsy. We aim to assess the utility of these models for patients with cognitive dysfunction. Among the evaluated patients, 17% had antibodies universally associated with autoimmune-encephalopathy. NMDA-R-IgG and LGI1-IgG were the most common antibody specificities. Antibody-Prevalence-in-Epilepsy-and-Encephalopathy (APE2) score ≥ 4 was 99% sensitive and 93% specific for neural-specific-antibodies. Responsive-to-immunotherapy-in-Epilepsy-and-Encephalopathy (RITE2) score ≥ 7 had 96% sensitivity and 86% specificity for favorable initial immunotherapy response. Application of these models may optimize autoantibody evaluations and immunotherapeutic trials.
Related Concept Videos
Tumor Immunotherapy
Cognitive Dissonance
Dose-Response Relationship: Selectivity and Specificity
Neural Regulation
Cognition and Behavior
Cognitive Learning
E. C. Tolman's theory of purposive behavior emphasizes that much behavior is goal-directed. He argued that to understand behavior, we must look at the entire sequence of actions leading to a goal. For instance, high school students study hard, not just due to past reinforcement but also to achieve the goal of getting into a good college.
Tolman introduced the idea that behavior is influenced by...

